These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 6304845

  • 1. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
    Ionescu C, Timoşca S, Petreanu V, Petreanu C, Georgescu M, Martinescu T.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
    [No Abstract] [Full Text] [Related]

  • 2. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
    Barbu Z, Alexa M, Josefovics F.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
    [No Abstract] [Full Text] [Related]

  • 3. [Survival of tuberculous bacilli in combined treatments including rifampicin].
    Kreis B, Pretet S.
    Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
    [No Abstract] [Full Text] [Related]

  • 4. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 5. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI, El'shanskaia MP.
    Probl Tuberk; 1973 Mar; 51(12):60-4. PubMed ID: 4205666
    [No Abstract] [Full Text] [Related]

  • 6. [Study of some rifampicin and ethambutol resistant strains of Mycobacteria isolated in the vicinity of the district of Jassy].
    Timoşca S, Petreanu V, Petreanu C, Ionescu L.
    Rev Med Chir Soc Med Nat Iasi; 1971 Mar; 75(1):119-25. PubMed ID: 5552548
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
    Golanov VS, Bogdalova VE, Andreev LP, Losin EI, Ushakova AG, Meshcheriakov VG, Bondin SV.
    Probl Tuberk; 1991 Mar; (12):27-8. PubMed ID: 1803368
    [Abstract] [Full Text] [Related]

  • 8. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P, Parrot R, Coury C.
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract] [Full Text] [Related]

  • 9. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F, Centrella G, Stefanelli R.
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract] [Full Text] [Related]

  • 10. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C, Sibila S.
    Ftiziologia; 1973 May; 22(5):477-84. PubMed ID: 4751363
    [No Abstract] [Full Text] [Related]

  • 11. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 12. [Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
    Rudoĭ NM, Zankisova IG, Eĭsaev BA.
    Antibiotiki; 1975 Oct; 20(10):945-8. PubMed ID: 813565
    [Abstract] [Full Text] [Related]

  • 13. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS, Gupta S, Lal S.
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR, Arseculeratne SN, Dasan P, Uragoda CG.
    Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
    [No Abstract] [Full Text] [Related]

  • 15. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV, Ushkin VV.
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract] [Full Text] [Related]

  • 16. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY, Gninafon M, Josse R, Kinde-Gazard D, Tawo L, Foundohou J.
    Bull Soc Pathol Exot; 1993 May; 86(2):144-7. PubMed ID: 8353477
    [Abstract] [Full Text] [Related]

  • 17. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
    Kozulicyna TI, Korotajev GA.
    G Ital Chemioter; 1972 May; 19(2):7-10. PubMed ID: 4199030
    [No Abstract] [Full Text] [Related]

  • 18. [Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].
    Alekseenko AM.
    Probl Tuberk; 1979 Jan; (1):33-7. PubMed ID: 105352
    [No Abstract] [Full Text] [Related]

  • 19. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

  • 20. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
    Tani P.
    Scand J Respir Dis Suppl; 1969 Jun; 69():15-6. PubMed ID: 4313500
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.